Elanco
The Director of Analytical Development leads a team focused on advancing Elanco's small molecule drug product pipeline. This leadership role is central to driving innovation and ensuring strong scientific and operational execution across pharmaceutical development programs.
Headquarters
Indianapolis, Indiana, United States
Company Size
5001-10000 employees
Founded
1954
As a global leader in animal health, Elanco provides innovative solutions to improve animal health and wellbeing for both farm animals and pets. For more than 70 years, Elanco has empowered veterinarians, farmers, and animal health professionals to transform animal care. Making life better for animals, makes life better.
Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?
11 hours ago
Why Elanco (ELAN) Is Down 8.2% After Guiding Higher 2026 Revenue Despite Ongoing Net Losses
2 days ago
Barrow Hanley Mewhinney & Strauss LLC Sells 2,592,747 Shares of Elanco Animal Health Incorporated $ELAN
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Elanco.
15% below the average for this role
Elanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum
1 day ago
Director, Analytical Development
Crinetics Pharmaceuticals
Analytical Development, Science and Technology Lead
Sobi
Analytical Development, Science and Technology Lead
Sobi
Senior Manager, Drug Product Analytics
Pfizer
Senior Scientist I - Peptide Analytical Chemistry
AbbVie
Principal Scientist, Analytical Development
Neurocrine Biosciences